February 28, 2017 / 12:54 AM / 5 months ago

BRIEF-vTv Therapeutics Q4 net loss per share of class A common stock $0.42

1 Min Read

Feb 27 (Reuters) - vTv Therapeutics Inc:

* vTv Therapeutics reports 2016 fourth quarter and full year financial and operational results and recent highlights

* vTv Therapeutics - believes cash and cash equivalents, funds from its credit facility will be sufficient to fund operations through Q1 of 2018

* Qtrly net loss per share of vTv Therapeutics Inc class A common stock $0.42 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below